Principal Investigator
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Haemodialysis
- Sponsor
- Akdeniz University
- Enrollment
- 70
- Locations
- 1
- Primary Endpoint
- Rationanl Drug use Scale
- Status
- Enrolling By Invitation
- Last Updated
- last year
Overview
Brief Summary
Patients with chronic kidney disease may show altered pharmacokinetic and pharmacodynamic response to many drugs compared to patients with normal renal function. Therefore, effective and safe drug use is difficult in patients with chronic kidney disease and especially in dialysis patients. In addition, some drugs may have nephrotoxic effects by causing further deterioration in renal function, especially in high-risk renal patients. Prevention of problems related to drug use in haemodialysis patients will be possible with rational drug use (RUD). RDM is defined as 'the set of rules to be followed in order for patients to take medicines in accordance with their clinical needs, in doses that meet their personal needs, in sufficient time, at the lowest cost to themselves and the society'.
Rational drug use has become an increasingly important concept today. In studies investigating rational drug use, problems such as incorrect use of drugs, prescribing more drugs than necessary, unnecessary injection recommendation/administration, unnecessary antibiotic consumption, and unnecessary use of expensive drugs have been identified. As a result of incorrect drug use, poisoning or decreased sensitivity to drugs are observed.
Detailed Description
The Effect of Education Based on Orem's Self-Care Deficit Theory and Tele-Monitoring on Rational Drug Use in Haemodialysis Patients
Investigators
Hatice CEYLAN
Asisstant Professor
Akdeniz University
Eligibility Criteria
Inclusion Criteria
- •18 years of age or older,
- •No communication or medically recognised mental problems,
- •Patients receiving haemodialysis treatment for 6 months or longer were included in the study.
Exclusion Criteria
- •Diagnosed with psychiatric illness
- •Diagnosed with malignancy
- •Individuals who do not allow access to their information.
Outcomes
Primary Outcomes
Rationanl Drug use Scale
Time Frame: two months
The Rational Drug Use Scale (RUDS) consists of 21 items and one dimension (Appendix 3). The items are scored on a 5-point Likert-type scale (1-Never, 2-Rarely, 3-Sometimes, 4-Most of the time and 5-Always) according to their fulfilment of the statements. Only the 17th item in the scale is reversed. After the reversed item is reversed, the sum of all scale items gives the 'total scale score'. The total score of the EHRS varies between 21 and 105. As the total score obtained from AİKÖ increases, rational drug use increases. When evaluating the total score obtained from AİKÖ; if the total score obtained is between 21- 52, it is scored as low level, between 53-67 as medium level, and between 68-105 as high level.